Mechanisms of Very Late DES Thrombosis by OCT

Original Title: Mechanisms of Very Late Drug-Eluting Stent Thrombosis Assessed by Optical Coherence Tomography. Reference: Masanori Taniwaki et al. Circulation. 2016 Feb 16;133(7):650-60.

 

The physiopathological mechanisms behind DES thrombosis have not been fully described yet. The potential causes behind this adverse event were assessed using optical computed tomography (OCT).

Between August 2010 and December 2014, 64 patients with instent very late thrombosis were included as part of an international OCT registry.
Very late thrombosis occurred at median 4.7 years after the original procedure (range 3.1 to 7.5 years).

After restoration of flow, OCT pullbacks were performed to analyze 38 first generation DES and 20 new generation DES; a possible cause was observed 98% of times.

The most frequent findings were strut malapposition (34.5%), neo atherosclerosis (27.6%), uncovered struts (12.1%) and stent underexpansion (6.9%).

Uncovered struts and malapposition were more frequent in thrombosed regions vs. non thrombosed.

Maximum stent length with absence or malapposed intimal covering (3.40 mm vs 1.29 mm; p<0.001) was a very strong predictor of thrombosis, but not malapposition distance (distance separating struts from intimal covering).

The combination of malapposition and absence of covering was consistent in both DES generations.

Conclusion
The most frequent causes of very late thrombosis were malapposition, neoatherosclerosis, uncovered struts and underexpansion, across first and new generation DES.

The maximal length of malapposed or uncovered struts showed the highest correlation with very late thrombosis.

More articles by this author

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

Rolling Stone: Registry of Intravascular Lithotripsy vs Atherectomy Use in Complex Calcified Lesions

Severe coronary calcification represents one of the main challenges in performing percutaneous coronary intervention, both due to the higher risk of stent underexpansion and...

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Low-Dose Rivaroxaban After Peripheral Angioplasty: Effectiveness and Safety in Real-World Clinical Practice

Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...